REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Drogas Pague Menos S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Drogas Pague Menos S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Drogas Pague Menos S.A.S. is based in Colombia. The head office is in Bucaramanga. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on November 09, 2018. The total number of employees is currently 239 (2024). The latest financial highlights indicate a net sales revenue increase of 3.2% in 2023. Its total assets decreased by 3.56% over the same period. In 2023, Drogas Pague Menos S.A.S.’s net profit margin decreased by 1.34%.

Headquarters
Cl 54 23 03 Brr Sotomayor
Bucaramanga; Santander;

Contact Details: Purchase the Drogas Pague Menos S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Drogas Pague Menos S.A.S. report to view the information.
Outstanding Shares:
Purchase the Drogas Pague Menos S.A.S. report to view the information.
Incorporation Date:
November 09, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Drogas Pague Menos S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
3.2%▲
Total operating revenue
3.19%▲
Operating profit (EBIT)
-31.43%▼
Net Profit (Loss) for the Period
-51.28%▼
Total assets
-3.56%▼
Total equity
41.77%▲
Operating Profit Margin (ROS)
-1.52%▼
Net Profit Margin
-1.34%▼
Return on Equity (ROE)
-55.75%▼
Quick Ratio
0.15%▲
Cash Ratio
0.15%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo